Helsinn Healthcare SA, The University of Texas MD Anderson Cancer Center enter strategic alliance to improve life of patients conducting clinical studies in cancer supportive and palliative care 26 April 2016
HELSINN GROUP SIGNS EXCLUSIVE AGREEMENT WITH PURDUE PHARMA CANADA FOR THE DISTRIBUTION AND LICENSING RIGHTS OF AKYNZEO® (NETUPITANT/PALONOSETRON combo) IN CANADA 26 April 2016
Helsinn announces publication of anamorelin ROMANA 1 and ROMANA 2 Phase III studies in The Lancet Oncology 24 March 2016
Linkedin